about
High Rate of Infection with Hepatitis C Virus Genotype 4 in a District of Galicia, SpainClinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendationsAutomated extraction improves multiplex molecular detection of infection in septic patientsMolecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in SpainImplication of p38 mitogen-activated protein kinase isoforms (alpha, beta, gamma and delta) in CD4+ T-cell infection with human immunodeficiency virus type I.Prevalence of HTLV infection in pregnant women in Spain.Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain.HTLV-1 infection and disease in Spain.Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients.X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain.Human immunodeficiency virus type 2 infection in Spain. The HIV-2 Spanish Study Group.HTLV infection in HCV-antibody positive patients in Spain.Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.Decline and changing profile of hepatitis delta among injection drug users in Spain.Construction and characterization of a minimized version of the HIV-1 pNL4-3 plasmid and its application for pseudotyping HIV-1 vectors.Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials.[Microbiological diagnosis of viral hepatitis].Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak.Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir.Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapyPrevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey.Very late HCV relapse following triple therapy for hepatitis C.HTLV infection among foreign pregnant women living in Spain.Hepatitis B virus genotyping based on cluster analysis of the region involved in lamivudine resistance.Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes.Unexpected results in BK virus detection by real-time PCR due to polymorphisms in the T-antigen gene.Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain.Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies.Young adults with spina bifida transitioned to a medical home: a survey of medical care in Jacksonville, Florida.Hepatitis Delta Enters a New Therapeutic Era.[CMV DNA detection in plasma using real-time PCR based on the SYBR-Green I dye method].Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.Septicemia caused by Corynebacterium macginleyi: a rare form of extraocular infection.Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain.
P50
Q27472603-25D8400D-C204-4DEF-90C2-75BB20906DF8Q28540964-841BE439-0BAF-43D9-999A-192DC018ABF2Q28748877-267DDE6D-5076-43F2-AE3A-F325CB80172CQ34116882-337CFA72-26C7-4DB9-B5BF-391DB9EAA449Q34786973-0E4D8D19-A255-412E-B017-D5CBBC659C3CQ35528954-284503AF-EF7E-4CA1-8B38-B09CE5B6FA05Q35916054-B0EC82A1-FFC6-4039-809E-93354E29EC82Q35994877-33E72A12-E3D3-4CED-8D2B-BC0F0F6AADFEQ36497842-018D637C-8E4E-4CD1-95E0-ED483ED70B57Q37526823-E7D6012D-9622-4170-B294-F79631809ADEQ38966290-AD22B001-0699-4C45-8B46-911CB38239F7Q38966303-11B6BB8E-62A0-4120-B286-BC59E8F9B3B8Q39443078-AC9C5EFC-0CD3-48CC-91C0-F9EC5F0FA887Q39461769-CCFEA95B-9903-4245-B972-622E854FFD92Q39511955-C0223F87-A79D-4866-A807-86A867DAC574Q39533345-8C7E2613-6C93-4617-90ED-8C27DEC3A2DFQ39533372-86D7DFEA-F1B8-4DF0-B6AE-46152B50AD3EQ40269048-880D8845-540F-40C4-A4CE-9CC06787EC30Q40505348-7C014B8A-776C-4289-BD6C-323BD059F16CQ40637791-452E1444-8515-4885-8019-E2874EDF584FQ41448052-D731D157-21D7-4F33-AE3F-76856FC0A6C1Q41589516-06F61CB8-808C-4395-8993-F591625C527CQ42263277-4E7AFDD3-F76A-4614-907D-F036744F27CFQ42264156-5B916F7B-F436-4C5E-8F15-9166F19A61A2Q42430831-0F7F7C99-CA59-461B-B4D6-EB48F5B19EC1Q42998901-5E9723DA-560C-4361-8396-21B37C83418DQ43000220-F62D61A4-5BB3-41E2-A50B-CA2CB8527EF4Q43454132-3BE0CE1B-2A97-494A-8357-8A0B314C582DQ44680511-E55E8388-B74E-4EEB-A1B3-AC2E81940E90Q45278159-11B64C73-C400-4BB6-99FE-A370610B6B84Q45344000-63EC71DF-0413-4954-B549-832394BFC2D1Q45480704-57D46E45-3415-4099-B8DF-82A8E6433569Q46100244-872845B5-4719-4200-87CC-9D43539F2754Q46772762-1AE5FBB4-7FC9-466D-8EC1-951308375656Q47980559-5472B879-72D3-4B52-AB4B-2535DEA13509Q50098858-226A2C92-3036-4E6F-978B-B2CDD2EB0205Q50707079-E7A3FAB7-2465-41C5-B249-DB39B616CFD9Q50760396-A5D0F10D-1520-42FB-AE9E-53791F71F887Q50871009-F9C18ADE-7E01-4D82-84C4-8CE0CB8D89A1Q53684291-728503CB-82BA-4DD1-B3E1-267E9FB35FB6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio Aguilera
@ast
Antonio Aguilera
@en
Antonio Aguilera
@es
Antonio Aguilera
@nl
Antonio Aguilera
@sl
type
label
Antonio Aguilera
@ast
Antonio Aguilera
@en
Antonio Aguilera
@es
Antonio Aguilera
@nl
Antonio Aguilera
@sl
prefLabel
Antonio Aguilera
@ast
Antonio Aguilera
@en
Antonio Aguilera
@es
Antonio Aguilera
@nl
Antonio Aguilera
@sl
P106
P21
P31
P496
0000-0001-6940-241X